# Tango Therapeutics, Inc. (TNGX) — capital_raise/atm_program [terminated]
Source: SEC API (secapi.ai) · situation sit_97850af9b801bf0e4bc4 · retrieved 2026-08-14T01:26:06.241Z

## Overview
Tango Therapeutics, Inc. is a pharmaceutical company engaged in the development of cancer therapeutics.

On August 11, 2026, Tango Therapeutics, Inc. filed a new prospectus supplement with the SEC to expand its at-the-market (ATM) offering program with Leerink Partners LLC. The new prospectus supplement permits the offering and sale of up to $400,000,000 in shares of common stock, which includes approximately $35,610,434 of unsold shares remaining from the prior prospectus supplement (which had authorized up to $100,000,000). The prior prospectus supplement offering has been terminated, and no further shares will be offered under it. The new offering is registered under the company's Form S-3ASR registration statement (File No. 333-291684), which became automatically effective upon filing on November 21, 2025.

## Terms
- Counterparty: Leerink Partners LLC · Deal value: $400.0M · Consideration: cash

## Key dates
- Terminated 2026-08-11

## Timeline
- 2026-08-11 · 8-K (0001193125-26-344997): 8-K - Tango Therapeutics, Inc. — *Tango Therapeutics, Inc. is a pharmaceutical company engaged in the development of cancer therapeutics.* On August 11, 2026, Tango Therapeutics, Inc. filed a new prospectus supplement with the SEC to expand its at-the-market (ATM) offering program with Leerink Partners LLC. The new prospectus supplement permits the offering and sale of up to $400,000,000 in shares of common stock, which includes approximately $35,610,434 of unsold shares remaining from the prior prospectus supplement (which had authorized up to $100,000,000). The prior prospectus supplement offering has been terminated, and no further shares will be offered under it. The new offering is registered under the company's Form S-3ASR registration statement (File No. 333-291684), which became automatically effective upon filing on November 21, 2025.
  https://www.sec.gov/Archives/edgar/data/1819133/0001193125-26-344997.txt

## Citations
- 0001193125-26-344997 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526344997